Department of Cardiology, Japan Community Healthcare Organization (JCHO) Osaka Hospital, 4-2-78, Fukushima, Fukushima-ku, Osaka, 553-0003, Japan.
Department of Cardiology, Japan Community Healthcare Organization (JCHO) Osaka Hospital, 4-2-78, Fukushima, Fukushima-ku, Osaka, 553-0003, Japan.
Indian Heart J. 2021 Sep-Oct;73(5):650-652. doi: 10.1016/j.ihj.2021.07.001. Epub 2021 Jul 20.
This study aimed to evaluate the clinical implication of the brachial-ankle pulse wave velocity (baPWV) for endovascular treatment (EVT). Eighty-four patients who underwent EVT for aortoiliac and femoropopliteal artery were included. In these patients, 36 (43 %) had an ABI improvement above 0.9 a day after EVT. The baPWV in patients who received re-EVT afterwards was significantly higher than that of patients who did not. The area under the receiver operating characteristic curve for the baPWV for predicting re-EVT was 0.788. The optimal cut-off values of the baPWV for re-EVT, specificity, and sensitivity were 2220 cm/s, 93.1 %, and 57.1 %, respectively.
本研究旨在评估肱踝脉搏波速度(baPWV)对血管内治疗(EVT)的临床意义。共纳入 84 例行 EVT 治疗的主髂动脉和股腘动脉患者。这些患者中,EVT 治疗后 1 天踝臂指数(ABI)改善>0.9 的有 36 例(43%)。随后接受再 EVT 的患者的 baPWV 明显高于未接受再 EVT 的患者。baPWV 预测再 EVT 的受试者工作特征曲线下面积为 0.788。再 EVT 的最佳 baPWV 截断值、特异性和敏感性分别为 2220cm/s、93.1%和 57.1%。